sj-pdf-1-msc-10.1177_0969141320930743 - Supplemental material for Systematic reviews as a 'lens of evidence': Determinants of participation in breast cancer screening

Autor: O Mandrik, E Tolma, N Zielonke, F Meheus, C Ordóñez-Reyes, JL Severens, R Murillo

Supplemental material, sj-pdf-1-msc-10.1177_0969141320930743 for Systematic reviews as a “lens of evidence”: Determinants of participation in breast cancer screening by O Mandrik, E Tolma, N Zielonke, F Meheus, C Ordóñez-Reyes, JL Severens and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2c3383ef76ba0e35e5c6697fa8edf4fc

Cost-effectiveness of tailored print communication, telephone motivational interviewing, and a combination of the two: results of an economic evaluation alongside the Vitalum randomized controlled trial

Autor: Hm, Keulen, Je, Bosmans, Mw, Tulder, Jl, Severens, de Vries H, Brug J, Ilse Mesters

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3c08896fe219b3f21b80ceaf3961a50b
http://europepmc.org/abstract/PMC/PMC3036596

The Association Between Physical Distancing Behaviors to Avoid COVID-19 and Health-Related Quality of Life in Immunocompromised and Nonimmunocompromised Individuals: Patient-Informed Protocol for the Observational, Cross-Sectional EAGLE Study.

Autor: Williams P; Global Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Patient Centered Solutions, IQVIA, Courbevoie, France., Herring TA; Medical Evidence, Epidemiology, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, United States., Yokota RTC; P95, Epidemiology & Pharmacovigilance, Leuven, Belgium., Maia T; Patient Centered Solutions, IQVIA, Porto Salvo, Portugal., Venkatesan S; BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Marcus JC; Patient Centered Solutions, IQVIA, Washington, DC, United States., Settergren G; Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Arnetorp S; Health Economic & Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Lloyd A; Acaster Lloyd Consulting Ltd, London, United Kingdom., Severens JL; Severens HTA Consultancy, Venray, Netherlands., Varni JW; Texas A&M University, College Station, TX, United States., Dixon S; Patient representative, Sulphur Springs, TX, United States., Hamusankwa L; Patient representative, London, United Kingdom., Powell PA; Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, United Kingdom.; Philip A Powell Consulting, Sheffield, United Kingdom., Taylor S; Medical Evidence, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Ware JE Jr; John Ware Research Group, Watertown, ME, United States., Krol M; Patient Centered Solutions, IQVIA, Amsterdam, Netherlands.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2024 Aug 13; Vol. 13, pp. e52643. Date of Electronic Publication: 2024 Aug 13.

EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.

Autor: Boonen A; Division of Rheumatology, Maastricht University Medical Centre+ Internal Medicine, Maastricht, The Netherlands a.boonen@mumc.nl.; Universiteit Maastricht Care and Public Health Research Institute, Maastricht, The Netherlands., Putrik P; Division of Rheumatology, Maastricht University Medical Centre+ Internal Medicine, Maastricht, The Netherlands.; Universiteit Maastricht Care and Public Health Research Institute, Maastricht, The Netherlands., Marques ML; Rheumatologist, Leiden University Medical Center, Leiden, The Netherlands.; Rheumatology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal., Alunno A; Rheumatology Unit, University of Perugia Department of Medicine, Perugia, Italy., Abasolo L; Department of Rheumatology, Instituto de Investigation Sanitaria San Carlos, Hospital Clinico Universitario San Carlos, Madrid, Spain., Beaton D; Mobility Program Clinical Research Unit, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada., Betteridge N; Neil Betteridge Associates, London, UK., Bjørk M; Pain and Rehabilitation Center, and Department of Health, Medicine and Caring Sciences, Linköping University, Linkoping, Sweden., Boers M; Department of Epidemiology and Data Science; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Amsterdam, The Netherlands., Boteva B; Patients with Arthritis and Rheumatism (PARE) working group, European League Against Rheumatism, Zurich, Switzerland., Fautrel B; PEPITES teams, Pierre Louis Institute for Epidemiology and Public Health, Inserm UMR 1136, Paris, France.; Rheumatology Dept, Pitié Salpetriere Hospital, Sorbonne University / Assistance Publique- Hôpitaux de Paris, Paris, Fance., Guillemin F; APEMAC, Université de Lorraine, Nancy, France.; CIC Epidémiologie Clinique, CHRU Nancy, Inserm, Université de Lorraine, Nancy, France., Mateus EF; Portuguese League Against Rheumatic Diseases (LPCDR) and Comprehensive Health Research Centre (CHRC), Lisbon, Portugal.; People with Arthritis and Rheumatism (PARE), European League Against Rheumatism, Zurich, Switzerland., Nikiphorou E; Centre for Rheumatic Diseases, King's College of London, London, UK.; Rheumatology Department, King's College Hospital, London, UK., Péntek M; Health Economics Research Center, University Research and Innovation Center, Óbuda University, Budapest, Hungary., Pimentel Santos F; Rheumatology Department, Centro Hospitalar de Lisboa Ocidental EPE Hospital de Egas Moniz, Lisboa, Portugal.; NOVA Medical School, Lisboa, Portugal., Severens JL; Erasmus School of Health Policy & Management and iMTA, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Verstappen SMM; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK., Walker-Bone K; MRC Versus Arthritis Centre for Musculoskeletal Health and Work, MRC Life course Epidemiology Unit, Southampton General Hospital, Southampton, UK., Wallman JK; Department of Clinical sciences, Lund University, Lund, Sweden.; Department of Rheumatology, Skåne University Hospital, Lund, Sweden., Ter Wee MM; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Rheumatology and immunology, AI&I, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Westhovens R; Dept of Rheumatology, KU Leuven University Hospitals Leuven, Leuven, Belgium.; Skeletal Biology and Engineering Research Centre, KU Leuven Department of Development and Regeneration, Leuven, Belgium., Ramiro S; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Sep; Vol. 80 (9), pp. 1116-1123. Date of Electronic Publication: 2021 Apr 08.

European survey on acute coronary syndrome diagnosis and revascularisation treatment: Assessing differences in reported clinical practice with a focus on strategies for specific patient cases.

Autor: Peultier AC; Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Venetsanos D; Coronary Artery and Vascular Disease, Heart and Vascular Theme, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden., Rashid I; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.; Case Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio., Severens JL; Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Redekop WK; Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Journal of evaluation in clinical practice [J Eval Clin Pract] 2020 Oct; Vol. 26 (5), pp. 1457-1466. Date of Electronic Publication: 2020 Jan 29.